ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,Y
2,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5,3,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
5,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
7,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
7,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
9,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11,4,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
13,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
13,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
15,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
15,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
16,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
17,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
17,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
20,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
20,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
20,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
21,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
21,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
22,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
22,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
23,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
24,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
24,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
25,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
25,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
25,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
27,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
28,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
29,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
29,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
29,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
30,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
30,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
30,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
31,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
32,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
33,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
34,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
34,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
36,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
37,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
37,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
38,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
39,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
39,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
39,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
40,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
41,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
42,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
43,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
43,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
44,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
45,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
46,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
46,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
47,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
47,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
49,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
49,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
49,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
50,1,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,Y
51,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
52,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
53,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
53,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
56,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
58,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
59,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
60,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
60,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
61,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
62,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
63,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
63,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
63,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
63,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
64,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
65,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
65,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
66,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
67,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
68,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
68,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
70,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
71,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
71,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
72,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
73,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
74,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
75,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
76,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
76,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
77,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
77,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
77,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
77,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
77,5,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
78,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,2,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
78,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
78,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
78,5,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
78,6,Vital capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
79,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
79,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
79,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
80,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
80,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
80,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
81,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
82,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
82,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
83,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
84,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
85,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
86,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
87,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
87,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
87,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
87,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
89,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
90,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
91,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
91,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
92,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
93,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
94,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
95,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
96,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
97,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
97,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
97,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
97,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
97,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
98,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
99,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
100,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
100,3,Nail operation,Nail therapeutic procedures,Skin and subcutaneous tissue therapeutic procedures,Surg,N
100,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
100,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
101,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
102,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
102,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
103,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
103,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
103,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
104,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
105,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
106,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
106,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
107,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
108,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
108,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
109,1,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
109,2,Urinary tract obstruction,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
110,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
110,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
110,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
111,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
112,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
113,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
113,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
114,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
115,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
115,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
116,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
116,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
117,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
118,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
119,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
120,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
121,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
121,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
121,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
122,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
123,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
124,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
125,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
125,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,Y
126,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
126,2,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
127,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
127,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
128,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
129,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
129,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
130,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
131,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
132,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
133,1,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
134,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
134,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
136,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
137,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
138,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
139,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
139,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
139,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
139,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
140,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
141,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
141,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
141,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
142,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
143,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
143,2,Headache,Headaches NEC,Headaches,Nerv,N
143,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
143,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
144,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
145,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
145,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
145,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
145,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
145,5,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
145,6,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
146,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
146,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
146,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
147,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
148,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
149,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
150,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
151,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
151,2,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
151,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
151,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
151,5,Metastases to the mediastinum,Metastases to specified sites,Metastases,Neopl,N
151,6,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
151,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
152,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
153,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
153,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
153,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
154,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
155,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
156,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
156,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
157,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
158,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
159,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
159,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
159,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
159,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
160,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
160,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
160,3,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
160,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
160,5,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
160,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
160,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
160,8,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
160,9,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
160,10,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
161,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
161,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
162,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
162,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
162,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
162,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
162,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
162,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
162,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
162,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
162,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
164,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
165,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
165,2,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
165,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
166,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
166,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
167,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
167,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
167,3,Headache,Headaches NEC,Headaches,Nerv,N
167,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
167,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
167,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
168,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
169,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
169,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
169,3,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
169,4,Oesophagectomy,Oesophageal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
169,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
169,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
169,7,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
169,8,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
169,9,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
170,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
170,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
171,2,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
171,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
171,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
172,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
172,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
172,3,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
172,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
172,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
172,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
172,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
172,8,Pupillary disorder,Pupil disorders,Ocular neuromuscular disorders,Eye,N
172,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
173,1,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
174,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
175,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
175,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
175,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
175,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
175,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
176,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
177,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
177,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
177,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
177,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
177,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
178,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
178,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
178,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
180,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
181,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
181,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
182,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
182,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
182,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
182,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
183,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
183,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
183,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
184,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
184,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
184,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
185,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
185,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
185,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
186,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
186,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
186,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
187,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
187,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
187,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
188,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
188,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
189,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
189,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
190,1,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
191,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
191,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
192,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
192,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
193,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
193,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
194,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
195,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
196,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
196,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
196,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
196,4,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
196,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
197,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
198,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
198,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
199,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
199,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
200,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
201,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
202,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
203,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
204,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
204,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
204,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
204,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
204,5,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
204,6,Tracheobronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
205,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
206,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
207,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
207,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
208,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
208,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
209,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
210,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
211,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
212,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
212,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
212,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
212,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
212,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
212,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
212,8,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
212,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
213,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
214,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
215,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
215,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
216,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
217,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
217,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
217,3,Migraine,Migraine headaches,Headaches,Nerv,N
217,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
218,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
218,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
218,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
219,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
220,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
220,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
221,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
222,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
223,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
223,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
224,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
224,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
225,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
225,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
226,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
226,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
227,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
227,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
227,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
228,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
228,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
228,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
229,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
229,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
230,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
231,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
232,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
233,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
234,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
235,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
235,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
237,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
237,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
237,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
237,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
237,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
238,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
238,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
238,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
239,1,Aortitis,Aortic infections and inflammations,Vascular infections and inflammations,Vasc,N
240,1,Pericarditis constrictive,Noninfectious pericarditis,Pericardial disorders,Card,Y
241,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
241,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
241,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
243,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
243,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
243,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
244,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
245,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
245,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
246,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
246,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
247,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
247,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
247,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
247,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
248,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
248,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
248,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
248,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
248,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
249,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
249,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
249,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
249,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
249,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
249,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
249,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
249,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
249,9,Tension headache,Headaches NEC,Headaches,Nerv,N
249,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
249,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
250,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
250,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
250,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
250,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
250,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
250,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
251,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
251,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
251,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
252,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
253,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
254,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
255,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
256,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
256,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
256,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
257,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
258,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
259,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
260,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
261,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
261,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
261,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
261,4,Flagellate dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
261,5,Melanoderma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
261,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
261,7,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
262,1,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
262,2,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
263,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
263,2,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
264,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
264,2,Secretory adenoma of pituitary,Hormone secreting pituitary neoplasms,Endocrine neoplasms malignant and unspecified,Neopl,N
265,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
267,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
267,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
268,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
268,2,Endocarditis candida,Candida infections,Fungal infectious disorders,Infec,N
268,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
268,4,Shunt malfunction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
269,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
269,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
270,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
270,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
271,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
273,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
274,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
275,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
276,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
276,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
277,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
277,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
278,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
278,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
278,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
278,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
278,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
279,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
279,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
280,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
280,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
281,2,Auscultation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
281,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
281,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
281,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
281,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
281,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
281,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
281,10,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
281,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
281,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,13,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
281,14,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
281,15,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
281,16,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
281,17,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
281,18,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
282,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
283,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
283,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
283,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
283,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
284,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
285,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
285,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
285,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
286,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
287,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
288,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
288,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
288,3,Myocardial oedema,Myocardial disorders NEC,Myocardial disorders,Card,N
288,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
288,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
290,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
291,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
291,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
291,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
291,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
291,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
291,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
292,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
292,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
293,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
294,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
294,2,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
294,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
294,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
294,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
294,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
294,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
294,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
295,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
296,1,Deafness,Hearing losses,Hearing disorders,Ear,N
296,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
296,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
297,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
298,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
299,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
299,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
299,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
299,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
300,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
301,1,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
301,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
301,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
301,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
301,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
301,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
301,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
302,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
303,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
304,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
305,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
305,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
305,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
305,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
306,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
306,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
307,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
308,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
309,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
310,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
310,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
311,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
311,2,Ovarian germ cell teratoma stage I,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
312,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,2,Ovarian germ cell teratoma stage I,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
313,1,Ovarian germ cell teratoma,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
314,1,Ovarian germ cell teratoma,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
315,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
316,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
317,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
318,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
319,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
319,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
319,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
320,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
320,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
320,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
320,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
320,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
320,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
320,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
320,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
321,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
322,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
322,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
323,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
323,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
323,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
324,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
324,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
325,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
325,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
325,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
326,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
327,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
327,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
328,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
329,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
329,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
330,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
330,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
330,3,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
331,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
331,2,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
332,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
333,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
333,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
333,3,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
334,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
334,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
335,1,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
336,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
336,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
337,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
338,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
339,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
339,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
339,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
339,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
339,6,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
340,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
340,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
340,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
340,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
340,5,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
341,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
341,2,Non-Hodgkin's lymphoma stage IV,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
342,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
343,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
343,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
344,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
345,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,2,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
346,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
346,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
347,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
348,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
348,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
348,3,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
349,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
350,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
350,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
350,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
350,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
350,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
350,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
351,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
351,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
352,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
352,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
353,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
353,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
353,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
353,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
354,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
355,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
357,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
357,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
357,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
357,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
357,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
357,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
357,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
358,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
359,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
359,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
360,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
360,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
360,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
360,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
360,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
360,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
360,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
360,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
361,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
362,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
362,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
362,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
362,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
362,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
362,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
362,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
363,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
363,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
364,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
364,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
364,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
364,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
364,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
364,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
364,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
364,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
365,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
365,2,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
365,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
365,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
365,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
365,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
365,7,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
365,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
365,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
